HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Web-only appendix All Versions of this Article: adc.2004.056317v1 90/4/F294    most recent Submit a response Read responses to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in ADC Online Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nestaas, E Articles by Wathne, K-O Search for Related Content PubMed PubMed Citation Articles by Nestaas, E Articles by Wathne, K-O Topic Collections Relevant Article

Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis

¹ Department of Paediatrics, Hospital of Vestfold, Tønsberg, Norway
² Department of Paediatrics, Ullevål University Hospital, Norway
³ Centre for Clinical Research, Ullevål University Hospital

Correspondence to:
Correspondence to:
Dr Nestaas
Department of Paediatrics, Hospital of Vestfold, PO Box 2168, Tønsberg 3103, Norway; eirikpda{at}start.no

Objectives: To review the evidence from controlled clinical trials of neonates given equal daily aminoglycoside doses as extended interval dosing (dosage interval typically 24 hours in term and 36–48 hours in immature neonates) compared with traditional dosing (dosage interval typically 8–12 hours in term and 12–24 hours in immature neonates).

Design: Systematic review and meta-analysis of controlled trials found in electronic databases, trial registers, and references in reviews and selected trials.

Settings: The selected trials were blinded and assessed for methodological quality. Each trial’s own predefined criteria for treatment failure, nephrotoxicity, ototoxicity, and therapeutic serum drug concentrations were used.

Subjects: Controlled trials of neonatal aminoglycoside treatment in which equal aminoglycoside daily doses were given at traditional and extended dosage intervals.

Main outcome measures: Serum drug concentrations outside the therapeutic range. Treatment failure and toxicity.

Results: Sixteen trials involving 823 neonates met the inclusion criteria for the systematic review. Twelve trials involving 698 neonates were included in the meta-analysis of the pharmacokinetics. Compared with traditional dosing, extended interval dosing was associated with a significantly lower risk of both peak (summary risk ratio 0.50, 95% confidence interval 0.26 to 0.94) and trough (0.36, 0.25 to 0.56) serum drug concentrations outside the therapeutic range. Accurate information on treatment failure was obtained in nine trials involving 555 neonates. One trial reported treatment failure. In this trial two neonates in the traditional dosing group did not respond to treatment within 72 hours. Nephrotoxicity was investigated in 589 neonates in 12 trials and ototoxicity in 210 neonates in four trials, with no significant differences between the two dosing regimens.

Conclusions: Extended interval dosing of aminoglycosides in neonates is safe and effective, with a reduced risk of serum drug concentrations outside the therapeutic range.

Abbreviations: CI, confidence interval; EID, extended interval dosing, typically 4–5 mg/kg gentamicin given to neonates at dosage interval 24 hours or longer; SDC, serum drug concentration; TD, traditional dosing, typically 2–3 mg/kg gentamicin given to neonates at dosage interval 8–24 hours

Keywords: aminoglycosides; drug dosing; meta-analysis; sepsis

Relevant Article

Fantoms

Martin Ward Platt
Arch. Dis. Child. Fetal Neonatal Ed. 2005 90: F283. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				K. Allegaert, I. Scheers, E. Adams, G. Brajanoski, V. Cossey, and B. J. Anderson Cerebrospinal Fluid Compartmental Pharmacokinetics of Amikacin in Neonates Antimicrob. Agents Chemother., June 1, 2008; 52(6): 1934 - 1939. [Abstract] [Full Text] [PDF]

				Is a once daily dose of gentamicin safe and effective in the treatment of uti in infants and children? Arch. Dis. Child., September 1, 2007; 92(9): 823 - 824. [Full Text] [PDF]

				P M Loughnan Single daily dose aminoglycosides in the neonatal period appear to be effective: but are they safe? Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2006; 91(2): F156 - F156. [Full Text] [PDF]

				A J B Emmerson and N E Edi-Osagie Reducing the dosing frequency of aminoglycosides can increase errors. Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2006; 91(2): F155 - F156. [Full Text] [PDF]

eLetters: